Navigation Links
Sosei Confirms the Safety of SD118 in Two Phase I Trials
Date:12/8/2008

sei.com

About NeuroDiscovery

NeuroDiscovery Ltd is an ASX listed speciality neuroscience services provider and drug development company which owns 100% of NeuroSolutions Ltd (ASX Code NDL).

About NeuroSolutions

NeuroSolutions Limited is a profitable service company, which has applied its broad spectrum expertise and drug discovery platforms to become a leading provider of specialised electrophysiological assays to the biopharmaceutical industry. Electrophysiology is a specialised technique which is used to record electrical activity in membranes, cells or tissues. NeuroSolutions' current clients include many established pharmaceutical and biotechnology companies.

In parallel to running its service business, the Company is also exploiting its in-house technologies and expertise for its own internal R&D and has a mature pipeline of programmes underway for the treatment of pain.

During 2008, the Company reported success in a Phase II trial for NSL-101. The Company also successfully completed two Phase I trials for the development compound NSL-043/SD118, in partnership with Sosei Co. Ltd. Both of these trials reported a successful outcome, facilitating further development.


'/>"/>
SOURCE Sosei Group Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting
2. Sosei Announces Completion of Phase III Trial for NorLevo(R)
3. National Study Presented at ACG 2008 Confirms New Device Functions Like Rear-View Mirror to Provide Improved View of the Colon
4. Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes
5. Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A
6. New Meta-Analysis Confirms Safety Profile for NeoRecormon in Treating Anaemia in Cancer Patients
7. New Data From Head-to-Head Study Confirms Once-Daily Levemir(R) is as Effective as Glargine over a 24-Hour Period in Subjects with Type 2 Diabetes
8. University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients
9. Study Confirms That Avastin Significantly Increases Chance of Living Without Disease Progression in Metastatic Breast Cancer
10. AviaraDx Confirms That Combination of Two Molecular Biomarkers Improves Prediction of Disease Recurrence in Early Stage Breast Cancer Patients
11. New Study Confirms Dose-Accuracy of SoloSTAR(R) Prefilled Insulin Pen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 2014  The orthopedic specialists at Midwest Orthopaedics ... orthopedic group by US News & World Report, are ... of free, public seminars to discuss partial and total ... come to see the knee physicians at Midwest Orthopaedics ... at Munster Specialty Surgery Center. The ...
(Date:9/30/2014)... 2014  Life Science Angels (LSA), a Bay ... emerging biotech, medical device, genomics, diagnostic and mobile ... Investment Group in the U.S.  LSA was recognized ... of 370 angel groups analyzed nationwide based on ... selection aptitude and brand recognition.  LSA was launched ...
(Date:9/30/2014)... 30, 2014  The Corporate Whistleblower Center is ... them at 866-714-6466 if they have well documented ... should have been sent home, as an intentional ... be substantial, as the Center would like to ... http://photos.prnewswire.com/prnh/20140929/149016 Photo - ...
Breaking Medicine Technology:"Knee Pain Solutions for Active Adults" Complimentary Seminars Open to the Public 2Life Science Angels Ranked the Top Angel Investment Group in the U.S. 2Life Science Angels Ranked the Top Angel Investment Group in the U.S. 3Corporate Whistleblower Center Urges ER Doctors or Nurse Managers to Call Them if They Have Proof of a Hospital Needlessly Admitting Medicare Patients Instead of Sending Them Home 2Corporate Whistleblower Center Urges ER Doctors or Nurse Managers to Call Them if They Have Proof of a Hospital Needlessly Admitting Medicare Patients Instead of Sending Them Home 3Corporate Whistleblower Center Urges ER Doctors or Nurse Managers to Call Them if They Have Proof of a Hospital Needlessly Admitting Medicare Patients Instead of Sending Them Home 4
... BUENOS AIRES, Argentina, May 21 Today at ... entitled "New,Perspectives in Atrial Fibrillation Management" chaired by ... of London,highlighted the importance of the newly announced ... the future management of Atrial,fibrillation, the most common ...
... Significant Reduction of IBS Pain and Normalizing Motility ... ... May 20 Tioga Pharmaceuticals, Inc. today,announced the results of ... agonist, asimadoline, which demonstrated statistically significant,results in the treatment of ...
Cached Medicine Technology:ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 2ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 3ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 4ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 5ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 6Tioga Pharmaceuticals' Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome 2Tioga Pharmaceuticals' Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome 3Tioga Pharmaceuticals' Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome 4
(Date:9/30/2014)... ADOAMNI, Inc. reached its ... GoFundMe. The campaign, which surpassed its goal in 17 ... the funds necessary to convert a diesel powered bus ... School District (SUSD). The campaign rallied citizens of the ... the funds necessary for the conversion of a SUSD ...
(Date:9/30/2014)... 2014 More than 23 per cent of Canadians report ... stress increases the risk of poor mental and physical health, ... but for others especially those most likely to sweat ... , Thankfully, new research from Concordia University has found a ... huge help for healthcare professionals working to stop stress before ...
(Date:9/30/2014)... the University of Pittsburgh School of Dental Medicine have ... National Institute of Dental and Craniofacial Research, part of ... of the genetic roots of cleft lip and cleft ... in Colombia, Nigeria, the Philippines and Pennsylvania. , ... lip or palate that can form when a baby,s ...
(Date:9/30/2014)... Cold Spring Harbor Laboratory (CSHL) will perform research in ... announced in Washington today. The CSHL grants are among ... Health (NIH), totaling $46 million for the 2014-15 fiscal ... Initiative. , The Brain Research through ... in the spring of 2013. It seeks to revolutionize ...
(Date:9/30/2014)... Albany, New York (PRWEB) September 30, 2014 ... Research, a U.S.-based market intelligence agency states that the ... a value of USD 18.5 billion by the end ... was valued at USD 10.3 billion in 2012, will ... develop into a USD 18.5 billion worth market by ...
Breaking Medicine News(10 mins):Health News:ADOMANI Raises More Than 100,000 Dollars Through GoFundMe to Convert a School Bus 2Health News:ADOMANI Raises More Than 100,000 Dollars Through GoFundMe to Convert a School Bus 3Health News:How to predict who will suffer the most from stress 2Health News:Pitt team searches for genetic roots of cleft lip, palate 2Health News:4 Cold Spring Harbor Laboratory scientists will contribute to President Obama's BRAIN Initiative under new NIH grants 2Health News:4 Cold Spring Harbor Laboratory scientists will contribute to President Obama's BRAIN Initiative under new NIH grants 3Health News:Global Medical Imaging Reagents Market Segment up to 2019: Transparency Market Research 2Health News:Global Medical Imaging Reagents Market Segment up to 2019: Transparency Market Research 3
... a familiar giant. Smokers around the world find it hard ... buy time by assuming that, cutting// down on the number ... latest research disagrees. ,A study published by ‘Tobacco Control’ ... number of cigarettes you smoke or continue to smoke 15 ...
... statin drug concluded that the drug has the potential to ... with no history of cardiovascular// diseases. But the reduce in ... drug. ,Statins, the best selling and widely ... lowering levels of artery-clogging 'bad' cholesterol, called LDL or low-density ...
... patients have to go through chemotherapy in their battle ... end with the treatment. Many patients complain of// unprecedented ... judgement and comprehension .This seemingly 'fuzzy' experience is also ... has found that these uncomfortable symptoms that trouble a ...
... has forced part of a Wellington based Rita Angus ... down. It has// closed its communal facilities after the ... faeces and vomit of infected people can spread easily ... food, touching surfaces and objects contaminated with the virus. ...
... million grant from the National Institutes of Health, researchers ... whether fat stored around the heart// accelerates the development ... accumulate in the abdomen, as well as around the ... hypothesis that fat around the arteries in the heart ...
... answer to what causes heart attacks is – atherosclerosis - ... on the walls of a coronary artery// until blood flow ... is not always the cause for having a heart attack. ... result in chest pain known as angina and other related ...
Cached Medicine News:Health News:For Smokers Only: is Quitting = Cutting Down?? a 'grave' Issue 2Health News:After Effects Of Chemotherapy Will Wane In Few Years :Says Research 2Health News:Researchers Study Effects Of Fat Around The Heart 2Health News:New Research Project Underway To Study Causes Of Heart Attack 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: